九州通董事长刘长云：满足老百姓的健康需求就是我们的发展动力

Group 1 - The chairman of Jiuzhoutong, Liu Changyun, emphasized the importance of the entrepreneurial spirit in driving the development of the private economy in China, highlighting the recognition of private enterprises' role by the state [2] - Liu noted that the digitalization and artificial intelligence are reshaping the pharmaceutical industry, presenting significant opportunities for private enterprises to enhance their core competitiveness [2] - Jiuzhoutong has established over 400 pharmaceutical logistics centers and has more than 5,000 grassroots delivery personnel, indicating a strong commitment to improving service systems and meeting healthcare needs [3] Group 2 - Jiuzhoutong's revenue is projected to exceed 150 billion yuan in 2024, positioning it as the largest private pharmaceutical commercial enterprise in China [3] - The company has implemented AI technology to enhance delivery efficiency by 40%, demonstrating its focus on innovation and operational improvement [3] - Liu emphasized the need for a sense of responsibility and long-term vision among entrepreneurs to effectively address healthcare demands [3]